TY  - GEN
AU  - Shigeno,Kazuyuki
AU  - Naito,Kensuke
AU  - Sahara,Naohi
AU  - Kobayashi,Miki
AU  - Nakamura,Satoki
AU  - Fujisawa,Sinya
AU  - Shinjo,Kaori
AU  - Takeshita,Akihiro
AU  - Ohno,Ryuzo
AU  - Ohnishi,Kazunori
TI  - Arsenic trioxide therapy in relapsed or refractory Japanese patients with acute promyelocytic leukemia: updated outcomes of the phase II study and postremission therapies
SN  - 0925-5710
PY  - 2006///0127
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Arsenic Trioxide
KW  - Arsenicals
KW  - Bone Marrow
KW  - pathology
KW  - Female
KW  - Humans
KW  - Japan
KW  - Leukemia, Promyelocytic, Acute
KW  - complications
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Proteins
KW  - biosynthesis
KW  - Oncogene Proteins, Fusion
KW  - Oxides
KW  - Recurrence
KW  - Remission Induction
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1532/IJH97.05044
ER  -